Application of ischemic postconditioning's algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies

被引:21
作者
Feyzizadeh, Saeid [1 ]
Badalzadeh, Reza [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran
关键词
ischaemic postconditioning; cardioprotection; ischaemia-reperfusion injuries; clinical studies; methodology; ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ATTENUATES INTESTINAL INJURY; CARDIOVASCULAR RISK-FACTORS; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; CARDIOPROTECTION; SIZE; RATS; MECHANISMS;
D O I
10.1111/jcmm.13159
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ischaemic postconditioning (IPostC) was introduced for the first time by Zhao et al. as a feasible method for reduction of myocardial ischaemia-reperfusion (IR) injury. The cardioprotection by this protocol has been extensively evaluated in various species. Then, further research revealed that IPostC is a safe and convenient approach in limiting IR injury of non-myocardial tissues such as lung, liver, kidney, intestine, skeletal muscle, brain and spinal cord. IPostC has been conducted with different algorithms, resulting in diverse effects. The possible important factors leading to these differences are the difference in activation levels of signalling pathways and protective mediators by any algorithm, presence or absence of IPostC effectors in each tissue, or intrinsic characteristics of the tissues as well as the methodological biases. Also, the conflicting results have been shown with the application of the same algorithm of IPostC in certain tissues or animal species. The effectiveness of IPostC may depend upon various parameters including the species and the tissues characteristics. For example, different heart rates and metabolic rates of the species and unequal amounts of perfusion and blood flow of the tissues should be considered as the important determinants of IPostC effectiveness and should be thought about in designing IPostC algorithms for future studies. Due to these discrepancies, there is still no optimal single IPostC algorithm applicable to any tissue or any species. This issue is the main topic of the present article.
引用
收藏
页码:2257 / 2267
页数:11
相关论文
共 70 条
[1]   Postconditioning Reduces Enzymatic Infarct Size and Improves Microvascular Reperfusion in Patients with ST-Segment Elevation Myocardial Infarction [J].
Araszkiewicz, Aleksander ;
Grygier, Marek ;
Pyda, Malgorzata ;
Rajewska, Justyna ;
Michalak, Michal ;
Lesiak, Maciej ;
Grajek, Stefan .
CARDIOLOGY, 2014, 129 (04) :250-257
[2]  
Badalzadeh R, 2015, ADV PHARM BULL, V5, P321, DOI 10.15171/apb.2015.045
[3]   The Additive Effects of Ischemic Postconditioning and Cyclosporine-A on Nitric Oxide Activity and Functions of Diabetic Myocardium Injured by Ischemia/Reperfusion [J].
Badalzadeh, Reza ;
Mohammadi, Mustafa ;
Najafi, Moslem ;
Ahmadiasl, Naser ;
Farajnia, Safar ;
Ebrahimi, Hadi .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (02) :181-189
[4]   Postconditioning signalling in the heart: mechanisms and translatability [J].
Bice, Justin S. ;
Baxter, Gary F. .
BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (08) :1933-1946
[5]   Measuring myocardial salvage [J].
Botker, Hans Erik ;
Kaltoft, Anne Kjer ;
Pedersen, Steen Fjord ;
Kim, Won Yong .
CARDIOVASCULAR RESEARCH, 2012, 94 (02) :266-275
[6]   Ischemic postconditioning: mechanisms, comorbidities, and clinical application [J].
Buchholz, Bruno ;
Donato, Martin ;
D'Annunzio, Veronica ;
Gelpi, Ricardo J. .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 392 (1-2) :1-12
[7]   Ischemia postconditioning preventing lung ischemia-reperfusion injury [J].
Cao, Qi-Feng ;
Qu, Mei-Jun ;
Yang, Wei-Qin ;
Wang, Dan-Ping ;
Zhang, Ming-Hui ;
Di, Song-Bo .
GENE, 2015, 554 (01) :120-124
[8]   Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat [J].
Chen, Hui ;
Xing, Bianzhi ;
Liu, Xiuheng ;
Zhan, Bingyan ;
Zhou, Jiangqiao ;
Zhu, Hengcheng ;
Chen, Zhiyuan .
TRANSPLANT INTERNATIONAL, 2008, 21 (04) :364-371
[9]   Measurement of myocardial infarct size in preclinical studies [J].
Csonka, Csaba ;
Kupai, Krisztina ;
Kocsis, Gabriella F. ;
Novak, Gabor ;
Fekete, Veronika ;
Bencsik, Peter ;
Csont, Tamas ;
Ferdinandy, Peter .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2010, 61 (02) :163-170
[10]   No Cardioprotective Benefit of Ischemic Postconditioning in Patients With ST-Segment Elevation Myocardial Infarction [J].
Dwyer, Nathan B. ;
Mikami, Yoko ;
Hilland, Darlene ;
Aljizeeri, Ahmed ;
Friedrich, Matthias G. ;
Traboulsi, Mouhieddin ;
Anderson, Todd J. .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (05) :482-490